
Photo: Photo: VCU Capital News Service via Flickr
The race for a COVID-19 is heating up. At least two COVID-19 vaccine makers ― Pfizer and Moderna ― may have enough clinical trial data to begin seeking U.S. regulatory approval in December, according to Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases.
“Somewhere around December, you will start to see companies with enough data… so they can move forward and apply for emergency-use authority from the FDA,” he told host Dr. Howard Bauchner at a Journal of the American Medical Association webcast on Oct. 28. “Then it could be granted. It could be January, or it could be later.” Continue reading